Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,142,145

« Back to Dashboard
Patent 6,142,145 protects PULMICORT FLEXHALER and is included in one NDA.

This patent has four patent family members in four countries.

Summary for Patent: 6,142,145

Title: Inhalation device
Abstract:An inhaler for administering powder by inhalation, including an inhaler body having two ends and a peripheral wall therebetween; an inhalation unit disposed in the inhaler body, the inhalation unit comprising an inhalation channel, the inhalation channel having an air inlet and an outlet; a dosing unit disposed in the inhaler body for providing a dose of powder to the inhalation channel such that a stream of air containing powder may be drawn from the outlet of the inhalation channel on inhalation by a user; a divider having a first surface bounded by a periphery and which substantially closes one end of the inhaler body; a mouthpiece attached to the periphery of the divider, the mouthpiece having a substantially radially directed flange which provides a second surface and which, together with the first surface, defines an air chamber; a first inlet for the air chamber provided in the first surface within the periphery of the divider and in fluid communication with the outlet of the inhalation channel; a second inlet for the air chamber disposed in the first surface within the periphery of the divider and adjacent the first inlet, a stream of supplementary air in use being drawn through the second inlet on inhalation by the user; and a discrete opening in peripheral wall of the inhaler body which is in fluid communication with the second inlet of the air chamber.
Inventor(s): Dagsland; Allan (Karlshamn, SE), Malmqvist-Granlund; Karin (Kavlinge, SE), Virtanen; Risto (Nurmijarvi, FI)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:09/068,379
Patent Claim Types:
see list of patent claims
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 23rd percentile
Forward Citations: 5th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
POWDER, METERED;INHALATION021949-001Jul 12, 2006RXYesNo6,142,145► subscribeY
POWDER, METERED;INHALATION021949-002Jul 12, 2006RXYesYes6,142,145► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,142,145

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9700940Mar 14, 1997
PCT Information
PCT FiledMarch 13, 1998PCT Application Number:PCT/SE98/00460
PCT Publication Date:September 24, 1998PCT Publication Number: WO98/41259

International Patent Family for Patent: 6,142,145

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia6430698► subscribe
European Patent Office0975382► subscribe
Sweden9700940► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.